Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2017

01-09-2017 | Original Article

Differences in prevalence of diabetes mellitus type 2 and impaired fasting glucose between urban and rural areas according to PURE Poland substudy

Authors: Katarzyna Zatońska, Katarzyna Połtyn-Zaradna, Jakub Einhorn, Maria Wołyniec, Dagmara Gaweł-Dąbrowska, Andrzej Szuba, Witold Zatoński

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2017

Login to get access

Abstract

This paper presents baseline results of the Prospective Urban Rural Epidemiology (PURE) Poland substudy of differences in prevalence of diabetes and impaired fasting glucose (IFG) between urban and rural areas. It covers group of 1643 people, aged 35 to 70 years old, inhabitants of Lower Silesia. The PURE study reached 22 countries with different statuses of economic development. All participants were tested in accordance to PURE project protocol. Data was collected at family (household) level and individual level. Diabetes was found in 12.0 % of our study population, IFG in 28.1 %, and normal glucose level in 59.9 %. Diabetes and IFG were more common in rural than in urban population, and higher percentage of people with diabetes was found in men comparing to women. In the PWBEC study conducted in years 1998–2000, diabetes prevalence was 5.3 %, in the NATPOL study conducted in years 1997–2002, 5.6 %; and in the latest PONS study from Świętokrzyskie voivodeship, 8.4 %. The percentage of people with diabetes in PURE Poland substudy was as high as 12 % and was higher than projections of diabetes prevalence in Poland for year 2030 (11.6 %). Significant differences of diabetes and IFG prevalence in respect to education and place of residence may arise from different attitudes of groups of patients to many other factors connected with prevention, treatment, and rehabilitation. Our study will continue to disclose other relevant risk factors in chosen areas.
Literature
4.
go back to reference Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7.CrossRefPubMed Zimmet P, Alberti KGMM, Shaw J. Global and societal implications of the diabetes epidemic. Nature. 2001;414(6865):782–7.CrossRefPubMed
10.
go back to reference Tsigos C, Hainer V, Basdevent A, Finer N, Fried M, Mathus-Vliegen E, et al. Management of obesity in adults: European clinical practice guidelines. Obes Facts. 2008;1(2):106–16. doi:10.1159/000126822.CrossRefPubMed Tsigos C, Hainer V, Basdevent A, Finer N, Fried M, Mathus-Vliegen E, et al. Management of obesity in adults: European clinical practice guidelines. Obes Facts. 2008;1(2):106–16. doi:10.​1159/​000126822.CrossRefPubMed
11.
go back to reference Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab. 1997;22:131–48. Shafrir E. Development and consequences of insulin resistance: lessons from animals with hyperinsulinaemia. Diabetes Metab. 1997;22:131–48.
12.
go back to reference Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998;21(7):1138–45.CrossRefPubMed Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the U.S. population, 1971-1993. Diabetes Care. 1998;21(7):1138–45.CrossRefPubMed
13.
go back to reference Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48(5):937–42.CrossRefPubMed Laakso M. Hyperglycemia and cardiovascular disease in type 2 diabetes. Diabetes. 1999;48(5):937–42.CrossRefPubMed
15.
go back to reference Grzeszczak W. Ryzyko rozwoju cukrzycy oraz jej powikłań–co nowego opublikowano na ten temat na początku 2011 roku? Choroby Serca i Naczyń. 2011;8(3):132–8. Grzeszczak W. Ryzyko rozwoju cukrzycy oraz jej powikłań–co nowego opublikowano na ten temat na początku 2011 roku? Choroby Serca i Naczyń. 2011;8(3):132–8.
16.
go back to reference Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92(11):2076–83.CrossRefPubMedPubMedCentral Huxley R, Ansary-Moghaddam A, Berrington de Gonzalez A, et al. Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer. 2005;92(11):2076–83.CrossRefPubMedPubMedCentral
17.
18.
go back to reference Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(22):1679–87.CrossRefPubMed Larsson SC, Orsini N, Wolk A. Diabetes mellitus and risk of colorectal cancer: a meta-analysis. J Natl Cancer Inst. 2005;97(22):1679–87.CrossRefPubMed
19.
go back to reference El–Seraq HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4(3):369–80.CrossRef El–Seraq HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol. 2006;4(3):369–80.CrossRef
20.
go back to reference Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49(12):2819–23.CrossRefPubMed Larsson SC, Orsini N, Brismar K, Wolk A. Diabetes mellitus and risk of bladder cancer: a meta-analysis. Diabetologia. 2006;49(12):2819–23.CrossRefPubMed
21.
go back to reference Kasper JS., Giovanucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 2006;15(11):2056–2062. Kasper JS., Giovanucci E. A meta-analysis of diabetes mellitus and the risk of prostate cancer. Cancer Epidemiol Biomark Prev 2006;15(11):2056–2062.
22.
go back to reference Friberg E, Orsini N, Mantzoros CS, Wolak A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365–74.CrossRefPubMed Friberg E, Orsini N, Mantzoros CS, Wolak A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia. 2007;50:1365–74.CrossRefPubMed
23.
go back to reference Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia. 1999;42(1):107–12.CrossRefPubMed Lindblad P, Chow WH, Chan J, et al. The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologia. 1999;42(1):107–12.CrossRefPubMed
24.
go back to reference Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121(4):856–62.CrossRefPubMed Larsson SC, Mantzoros CS, Wolk A. Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer. 2007;121(4):856–62.CrossRefPubMed
25.
go back to reference Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86(3):823–35. Xue F, Michels KB. Diabetes, metabolic syndrome, and breast cancer: a review of the current evidence. Am J Clin Nutr. 2007;86(3):823–35.
26.
go back to reference Nowakowski A. Epidemiologia cukrzycy. Diabetol Prakt. 2002;3:181–5. Nowakowski A. Epidemiologia cukrzycy. Diabetol Prakt. 2002;3:181–5.
27.
go back to reference Sieradzki J. Cukrzyca. Gdańsk: Wydawnictwo Via Medica; 2006. Sieradzki J. Cukrzyca. Gdańsk: Wydawnictwo Via Medica; 2006.
28.
go back to reference Sulicka J, Fornal M, Gryglewska B, Wizner B, Grodzicki T. Selected cardiovascular risk factors in primary care patients. Arterial Hypertension. 2006;10:370–6. Sulicka J, Fornal M, Gryglewska B, Wizner B, Grodzicki T. Selected cardiovascular risk factors in primary care patients. Arterial Hypertension. 2006;10:370–6.
29.
go back to reference Kawalec P, Kielar M, Pilc A. Koszty leczenia cukrzycy typu 1 i 2 w Polsce. Diabetologia Praktyczna. 2006;7(5):287–94. Kawalec P, Kielar M, Pilc A. Koszty leczenia cukrzycy typu 1 i 2 w Polsce. Diabetologia Praktyczna. 2006;7(5):287–94.
31.
go back to reference Teo K, Chow CK, Vaz M, Rangarajan S. Yusuf S; PURE Investigators-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158(1):1–7. doi:10.1016/j.ahj.2009.04.019.CrossRefPubMed Teo K, Chow CK, Vaz M, Rangarajan S. Yusuf S; PURE Investigators-Writing Group. The Prospective Urban Rural Epidemiology (PURE) study: examining the impact of societal influences on chronic noncommunicable diseases in low-, middle-, and high-income countries. Am Heart J. 2009;158(1):1–7. doi:10.​1016/​j.​ahj.​2009.​04.​019.CrossRefPubMed
32.
go back to reference Szybiński Z. Polskie Wieloośrodkowe Badania nad Epidemiologią Cukrzycy (PWBEC)-1998-2000. Pol Arch Med Wewn. 2001;3:751–91. Szybiński Z. Polskie Wieloośrodkowe Badania nad Epidemiologią Cukrzycy (PWBEC)-1998-2000. Pol Arch Med Wewn. 2001;3:751–91.
33.
go back to reference Zdrojewski T, Bandosz P, Szpakowski P, et al. Ocena wybranych problemów dotyczących wybranych terapii nadciśnienia tętniczego w Polsce na podstawie badania NATPOL III PLUS. In: Więcek A, Kokot F, editors. Postępy w nefrologii i nadciśnieniu tętniczym. T. II. Krąków: Medycyna Prakt; 2003. p. 11–5. Zdrojewski T, Bandosz P, Szpakowski P, et al. Ocena wybranych problemów dotyczących wybranych terapii nadciśnienia tętniczego w Polsce na podstawie badania NATPOL III PLUS. In: Więcek A, Kokot F, editors. Postępy w nefrologii i nadciśnieniu tętniczym. T. II. Krąków: Medycyna Prakt; 2003. p. 11–5.
34.
go back to reference Zatońska K, Ilow R, Regulska-Ilow B, Różańska D, Szuba A, Wołyniec M, Einhorn J, Vatten L, Asvold BC, Mańczuk M, Zatoński WA. Prevalence of diabetes mellitus and IFG in the prospective cohort ’PONS’ study—baseline assessment. Ann Agric Environ Med. 2011;18(2):265–9.PubMed Zatońska K, Ilow R, Regulska-Ilow B, Różańska D, Szuba A, Wołyniec M, Einhorn J, Vatten L, Asvold BC, Mańczuk M, Zatoński WA. Prevalence of diabetes mellitus and IFG in the prospective cohort ’PONS’ study—baseline assessment. Ann Agric Environ Med. 2011;18(2):265–9.PubMed
35.
go back to reference Korzeniowska K, Jabłecka A. Cukrzyca (część I). Farmacja wspołczesna. 2008;1:231–5. Korzeniowska K, Jabłecka A. Cukrzyca (część I). Farmacja wspołczesna. 2008;1:231–5.
36.
go back to reference Bandurska-Stankiewicz B, Myszka-Podgórska K, Cylkowska B, Surdykowski L, Moczulska B. Częstość występowania cukrzycy nieznanej i stanów przed cukrzycowych w populacji województwa warmińsko-mazurskiego. Przegląd Kardiologiczny. 2007;2(1):41–7. Bandurska-Stankiewicz B, Myszka-Podgórska K, Cylkowska B, Surdykowski L, Moczulska B. Częstość występowania cukrzycy nieznanej i stanów przed cukrzycowych w populacji województwa warmińsko-mazurskiego. Przegląd Kardiologiczny. 2007;2(1):41–7.
37.
go back to reference Gillam S, Yates J, Badrinath P. Essential public health, Cambridge; 2007;78–79. Gillam S, Yates J, Badrinath P. Essential public health, Cambridge; 2007;78–79.
38.
go back to reference Czupryniak L. Nowe trendy w Diabetologii 2012/2013. Poznań: Temida; 2012. p. 15–6. Czupryniak L. Nowe trendy w Diabetologii 2012/2013. Poznań: Temida; 2012. p. 15–6.
39.
go back to reference Lear SA, Teo K, et al., on behalf of the Prospective Urban Rural Epidemiology (PURE) study. The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries. CMAJ. 186(4):258–66. doi:10.1503/cmaj.131090. Lear SA, Teo K, et al., on behalf of the Prospective Urban Rural Epidemiology (PURE) study. The association between ownership of common household devices and obesity and diabetes in high, middle and low income countries. CMAJ. 186(4):258–66. doi:10.​1503/​cmaj.​131090.
Metadata
Title
Differences in prevalence of diabetes mellitus type 2 and impaired fasting glucose between urban and rural areas according to PURE Poland substudy
Authors
Katarzyna Zatońska
Katarzyna Połtyn-Zaradna
Jakub Einhorn
Maria Wołyniec
Dagmara Gaweł-Dąbrowska
Andrzej Szuba
Witold Zatoński
Publication date
01-09-2017
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2017
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-016-0523-4

Other articles of this Issue 3/2017

International Journal of Diabetes in Developing Countries 3/2017 Go to the issue